Cat. No. | Product name | CAS No. |
DC10115 |
Piperoxan hydrochloride
Featured
Piperoxan hydrochloride is an α2 adrenoceptor antagonist. |
135-87-5 |
DC8112 |
Pirarubicin(THP)
Featured
Pirarubicin is an analogue of the anthracycline anti-neoplastic doxorubicin, which is an inhibitor of Topo II. |
72496-41-4 |
DC8792 |
Pirfenidone(AMR69)
Featured
Pirfenidone(AMR69) is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties. Phase 3. |
53179-13-8 |
DC10012 |
Pirmenol hydrochloride
Featured
Pirmenol hydrochloride inhibits IK.ACh by blocking muscarinic receptors. The IC50 of Pirmenol for inhibition of Carbachol-induced IK.ACh is 0.1 μM. |
61477-94-9 |
DC10364 |
(±)-Pirmenol
Featured
Pirmenol inhibits IK.ACh by blocking muscarinic receptors. The IC50 of Pirmenol for inhibition of Carbachol-induced IK.ACh is 0.1 μM. |
68252-19-7 |
DC7155 |
Pirodavir (R 77975)
Featured
Pirodavir (R 77975) is the prototype of a novel class of broad-spectrum antipicornavirus compounds; potent human rhinovirus (HRV) capsid-binding inhibitor. |
124436-59-5 |
DCAPI1470 |
Pitavastatin Calcium
Featured
Pitavastatin Calcium is a competitive inhibitor of the enzyme HMGCR (HMG-CoA reductase) results in a reduction in LDL cholesterol synthesis. Alternate studies show that pitavastatin can suppress oxygen production in endothelial cells by inhibiting NADPH o |
147526-32-7 |
DC9465 |
Pitolisant (hydrochloride)
Featured
Pitolisant Hcl(BF2.649;Ciproxidine ) is a novel, potent, and selective nonimidazole inverse agonist at the recombinant human H3 receptor (Ki=0.16 nM). |
903576-44-3 |
DC21940 |
Pizuglanstat
Featured
Pizuglanstat is a potent, selective prostaglandin D synthase inhibitor.. |
1244967-98-3 |
DC7237 |
PJ34 HCl
Featured
PJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2. |
344458-15-7 |
DC7634 |
PKC-412 (Midostaurin)
Featured
PKC-412 is a broad spectrum protein kinase inhibitor. Inhibits conventional PKC isoforms (α, β, γ), PDFRβ, VEGFR2, Syk, PKCη, Flk-1, Flt3, Cdk1/B, PKA, c-Kit, c-Fgr, c-Src, VEGFR1 and EGFR. Displays potent antitumor activity. |
120685-11-2 |
DC10821 |
PKG drug G1
Featured
PKG drug G1 has been shown to induce the oxidative activation of protein kinase G Iα, which in vivo results in dilation of blood vessel and blood pressure lowering; an antihypertensive. |
374703-78-3 |
DC7238 |
Gedatolisib(PKI-587)
Featured
PKI-587 is a highly potent dual PI3K/mTOR kinase inhibitor with IC50 of 0.4 nM and <0.1 μM for PI3K-α and mTOR, respectively. |
1197160-78-3 |
DC12462 |
PLB-1001
Featured
Bozitinib (PLB-1001) is a highly selective c-MET kinase inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) is a ATP-competitive small-molecule inhibitor, binds to the conventional ATP-binding pocket of the tyrosine kinase superfamily[1]. |
1440964-89-5 |
DC20012 |
Plecanatide acetate
Featured
Plecanatide acetate is a guanylate cyclase-C (GC-C) receptor agonist, binds and activates GC-C receptor, with an EC50 of 190 nM in T84 cells. Plecanatide acetate shows an-inflammatory activity in models of murine colitis. |
1075732-84-1 |
DC10016 |
Pleconarilis
Featured
Pleconarilis is a picornavirus replication inhibitor. |
153168-05-9 |
DC5055 |
Plerixafor (AMD3100)
Featured
Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively. |
110078-46-1 |
DC8741 |
Plerixafor octahydrochloride
Featured
Plerixafor octahydrochloride(AMD3100 8HCL) is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively. |
155148-31-5 |
DC8749 |
Plinabulin
Featured
Plinabulin (NPI-2358) is a vascular disrupting agents (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. |
714272-27-2 |
DC7239 |
PluriSln 1(NSC 14613)
Featured
PluriSln 1(NSC 14613) is an inhibitor of stearoyl-coA desaturase (SCD1), the key enzyme in oleic acid biosynthesis, revealing a unique role for lipid metabolism in hPSCs. |
91396-88-2 |
DC8158 |
Pexidartinib(PLX3397)
Featured
PLX3397 is a tyrosine kinase inhibitor that potently inhibits the colony stimulating factor 1 (CSF1) receptor kinase, a driving force in the development and growth of PVNS. |
1029044-16-3 |
DC1071 |
Vemurafenib (PLX4032)
Featured
PLX4032 (Vemurafenib, RG7204, Zelboraf, RO5185426) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM. |
918504-65-1 |